Open Life Sciences (Feb 2022)

Regulation of miR-30b in cancer development, apoptosis, and drug resistance

  • Fu Zhen-Jie,
  • Chen Yan,
  • Xu Yu-Qin,
  • Lin Mei-Ai,
  • Wen Hang,
  • Chen Yi-Tao,
  • Pan Pei-Lei

DOI
https://doi.org/10.1515/biol-2022-0017
Journal volume & issue
Vol. 17, no. 1
pp. 102 – 106

Abstract

Read online

miR-30b, which is encoded by the gene located on chromosome 8q24.22, plays an important role in a variety of diseases. In most types of tumors, miR-30b significantly inhibits the proliferation, migration, and invasion of cancer cells through the regulation of target genes. Moreover, miR-30b can inhibit the PI3K/AKT signaling pathway through the regulation of EGFR, AKT, Derlin-1, GNA13, SIX1, and other target genes, thus inhibiting the EMT process of tumor cells and promoting apoptosis. In addition, miR-30 plays a significant role in alleviating drug resistance in tumor cells. Although the use of miR-30b as a clinical diagnostic indicator or anticancer drug is still facing great difficulties in the short term, with the deepening of research, the potential application of miR-30b is emerging.

Keywords